TapewireFind a company

person · Reporting owner

DeSieno Alexis

Disclosed activity across 1 company

Tapewire entity
70368
SEC CIK
0001987391

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Cardlytics, Inc.CDLX · Entity 7603Chief Financial OfficerJanuary 01, 2026January 05, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Cardlytics, Inc.

Report date January 01, 2026 · Filed January 05, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect201,159 Ending reported balance After 2026-01-05 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2026-01-01 · Exercise / conversion · Acquired 14,349 · Balance 209,766

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

Row 2 · 2026-01-05 · Sale · Disposed 8,607 · Balance 201,159

F2: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on January 1, 2026. The Reporting Person did not sell shares for any other purpose.

F3: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.12 to $1.235, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect14,350 Reported balance After 2026-01-01 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-01-01 · Exercise / conversion · Disposed 14,349 · Balance 14,350

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

F4: The RSU award was originally for 114,796 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

F2: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on January 1, 2026. The Reporting Person did not sell shares for any other purpose.

F3: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.12 to $1.235, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).

F4: The RSU award was originally for 114,796 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
January 05, 2026 Filed Jan 5, 2026 23:47 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 8,607 $1.17 $10,070.19
Disclosure

SEC source: 0001628280-26-000721 · wk-form4_1767656830.xml · nonDerivative · entry 2

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 201,159

F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on January 1, 2026. The Reporting Person did not sell shares for any other purpose.

F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.12 to $1.235, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).

Read SEC document
January 01, 2026 Filed Jan 5, 2026 23:47 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Units · Derivative 14,349 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-000721 · wk-form4_1767656830.xml · derivative · entry 3

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,350

Underlying: Common Stock · 14,349 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

F4 · derivative.exercise_date: The RSU award was originally for 114,796 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F4 · derivative.expiration_date: The RSU award was originally for 114,796 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
January 01, 2026 Filed Jan 5, 2026 23:47 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 14,349 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-000721 · wk-form4_1767656830.xml · nonDerivative · entry 1

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 209,766

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

Read SEC document
October 02, 2025 Filed Oct 2, 2025 23:02 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 8,493 $2.27 $19,287.60
Disclosure

SEC source: 0001666071-25-000139 · wk-form4_1759446153.xml · nonDerivative · entry 2

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 195,417

F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on October 1, 2025. The Reporting Person did not sell shares for any other purpose.

F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.21 to $2.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).

Read SEC document
October 01, 2025 Filed Oct 2, 2025 23:02 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Units · Derivative 14,350 $0.00 $0.00
Disclosure

SEC source: 0001666071-25-000139 · wk-form4_1759446153.xml · derivative · entry 3

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,699

Underlying: Common Stock · 14,350 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

F4 · derivative.exercise_date: The RSU award was originally for 114,796 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F4 · derivative.expiration_date: The RSU award was originally for 114,796 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
October 01, 2025 Filed Oct 2, 2025 23:02 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 14,350 Not disclosed Not disclosed
Disclosure

SEC source: 0001666071-25-000139 · wk-form4_1759446153.xml · nonDerivative · entry 1

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 203,910

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

Read SEC document
August 15, 2025 Filed Aug 18, 2025 20:07 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 26,048 $1.22 $31,700.42
Disclosure

SEC source: 0001666071-25-000128 · wk-form4_1755547624.xml · nonDerivative · entry 2

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 189,560

F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on August 14, 2025. The Reporting Person did not sell shares for any other purpose.

F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.19 to $1.265, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).

Read SEC document
August 14, 2025 Filed Aug 18, 2025 20:07 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Units · Derivative 43,750 $0.00 $0.00
Disclosure

SEC source: 0001666071-25-000128 · wk-form4_1755547624.xml · derivative · entry 3

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 43,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

F4 · derivative.exercise_date: The RSU award was originally for 350,000 shares. 50% of the RSUs vested on August 14, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over the one year period following the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F4 · derivative.expiration_date: The RSU award was originally for 350,000 shares. 50% of the RSUs vested on August 14, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over the one year period following the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
August 14, 2025 Filed Aug 18, 2025 20:07 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 43,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001666071-25-000128 · wk-form4_1755547624.xml · nonDerivative · entry 1

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215,608

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

Read SEC document
July 02, 2025 Filed Jul 2, 2025 22:36 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 7,324 $1.78 $13,055.76
Disclosure

SEC source: 0001666071-25-000116 · wk-form4_1751495809.xml · nonDerivative · entry 2

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,858

F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on July 1, 2025. The Reporting Person did not sell shares for any other purpose.

F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.66 to $1.8451, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).

Read SEC document
July 01, 2025 Filed Jul 2, 2025 22:36 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Units · Derivative 14,349 $0.00 $0.00
Disclosure

SEC source: 0001666071-25-000116 · wk-form4_1751495809.xml · derivative · entry 3

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,049

Underlying: Common Stock · 14,349 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

F4 · derivative.exercise_date: The RSU award was originally for 114,796 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F4 · derivative.expiration_date: The RSU award was originally for 114,796 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
July 01, 2025 Filed Jul 2, 2025 22:36 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 14,349 Not disclosed Not disclosed
Disclosure

SEC source: 0001666071-25-000116 · wk-form4_1751495809.xml · nonDerivative · entry 1

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,182

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

Read SEC document
June 23, 2025 Filed Jun 25, 2025 20:13 UTC Cardlytics, Inc. CDLX · Entity 7603 GrantPerformance Stock Unit · Derivative 15,000 $0.00 $0.00
Disclosure

SEC source: 0001666071-25-000111 · wk-form4_1750882385.xml · derivative · entry 2

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: The PSU vests in specified percentages upon achievement of specified price per share targets, provided that the Reporting Person remains employed by the Issuer on such vesting dates.

F4 · derivative.expiration_date: The PSU vests in specified percentages upon achievement of specified price per share targets, provided that the Reporting Person remains employed by the Issuer on such vesting dates.

Read SEC document
June 23, 2025 Filed Jun 25, 2025 20:13 UTC Cardlytics, Inc. CDLX · Entity 7603 GrantRestricted Stock Units · Derivative 40,000 $0.00 $0.00
Disclosure

SEC source: 0001666071-25-000111 · wk-form4_1750882385.xml · derivative · entry 1

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: 50% of the shares underlying the RSU award will vest on June 23, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through June 23, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates.

F2 · derivative.expiration_date: 50% of the shares underlying the RSU award will vest on June 23, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through June 23, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates.

Read SEC document
May 15, 2025 Filed May 16, 2025 20:03 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 26,217 $1.94 $50,808.55
Disclosure

SEC source: 0001666071-25-000071 · wk-form4_1747425789.xml · nonDerivative · entry 2

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,833

F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on May 14, 2025. The Reporting Person did not sell shares for any other purpose.

F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.88 to $2.035, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).

Read SEC document
May 14, 2025 Filed May 16, 2025 20:03 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Units · Derivative 43,750 $0.00 $0.00
Disclosure

SEC source: 0001666071-25-000071 · wk-form4_1747425789.xml · derivative · entry 3

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,750

Underlying: Common Stock · 43,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

F4 · derivative.exercise_date: The RSU award was originally for 350,000 shares. 50% of the RSUs vested on August 14, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over the one year period following the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F4 · derivative.expiration_date: The RSU award was originally for 350,000 shares. 50% of the RSUs vested on August 14, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over the one year period following the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
May 14, 2025 Filed May 16, 2025 20:03 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 43,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001666071-25-000071 · wk-form4_1747425789.xml · nonDerivative · entry 1

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,050

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

Read SEC document
April 02, 2025 Filed Apr 3, 2025 20:11 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 7,998 $1.81 $14,444.39
Disclosure

SEC source: 0001666071-25-000052 · wk-form4_1743711105.xml · nonDerivative · entry 2

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,300

F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on April 1, 2025. The Reporting Person did not sell shares for any other purpose.

F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.78 to $1.865, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).

Read SEC document
April 01, 2025 Filed Apr 3, 2025 20:11 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Units · Derivative 14,350 $0.00 $0.00
Disclosure

SEC source: 0001666071-25-000052 · wk-form4_1743711105.xml · derivative · entry 3

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,398

Underlying: Common Stock · 14,350 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

F4 · derivative.exercise_date: The RSU award was originally for 114,796 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F4 · derivative.expiration_date: The RSU award was originally for 114,796 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
April 01, 2025 Filed Apr 3, 2025 20:11 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 14,350 Not disclosed Not disclosed
Disclosure

SEC source: 0001666071-25-000052 · wk-form4_1743711105.xml · nonDerivative · entry 1

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,298

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

Read SEC document
March 19, 2025 Filed Mar 22, 2025 00:54 UTC Cardlytics, Inc. CDLX · Entity 7603 GrantRestricted Stock Unit · Derivative 135,000 $0.00 $0.00
Disclosure

SEC source: 0001666071-25-000039 · wk-form4_1742604834.xml · derivative · entry 2

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 135,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: 50% of the shares underlying the RSU award will vest on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates.

F4 · derivative.expiration_date: 50% of the shares underlying the RSU award will vest on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates.

Read SEC document
March 19, 2025 Filed Mar 22, 2025 00:54 UTC Cardlytics, Inc. CDLX · Entity 7603 GrantPerformance Stock Unit · Derivative 50,625 $0.00 $0.00
Disclosure

SEC source: 0001666071-25-000039 · wk-form4_1742604834.xml · derivative · entry 1

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,625 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The PSU vests in specified percentages upon achievement of specified price per share targets, provided that the Reporting Person remains employed by the Issuer on such vesting dates.

F2 · derivative.expiration_date: The PSU vests in specified percentages upon achievement of specified price per share targets, provided that the Reporting Person remains employed by the Issuer on such vesting dates.

Read SEC document
February 18, 2025 Filed Feb 18, 2025 23:39 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 24,778 $3.40 $84,195.64
Disclosure

SEC source: 0001666071-25-000022 · wk-form4_1739921943.xml · nonDerivative · entry 2

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,948

F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on February 14, 2025. The Reporting Person did not sell shares for any other purpose.

F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $3.285 to $3.515, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).

Read SEC document
February 14, 2025 Filed Feb 18, 2025 23:39 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Units · Derivative 43,750 $0.00 $0.00
Disclosure

SEC source: 0001666071-25-000022 · wk-form4_1739921943.xml · derivative · entry 3

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,500

Underlying: Common Stock · 43,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

F4 · derivative.exercise_date: The RSU award was originally for 350,000 shares. 50% of the RSUs vested on August 14, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over the one year period following the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F4 · derivative.expiration_date: The RSU award was originally for 350,000 shares. 50% of the RSUs vested on August 14, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over the one year period following the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 23:39 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 43,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001666071-25-000022 · wk-form4_1739921943.xml · nonDerivative · entry 1

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,726

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

Read SEC document
January 03, 2025 Filed Jan 6, 2025 22:52 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 8,854 $3.67 $32,467.62
Disclosure

SEC source: 0001666071-25-000010 · wk-form4_1736203958.xml · nonDerivative · entry 2

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,976

F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on January 1, 2025. The Reporting Person did not sell shares for any other purpose.

F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $3.555 to $3.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).

Read SEC document
January 01, 2025 Filed Jan 6, 2025 22:52 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Units · Derivative 14,349 $0.00 $0.00
Disclosure

SEC source: 0001666071-25-000010 · wk-form4_1736203958.xml · derivative · entry 3

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,748

Underlying: Common Stock · 14,349 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

F4 · derivative.exercise_date: The RSU award was originally for 114,796 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F4 · derivative.expiration_date: The RSU award was originally for 114,796 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
January 01, 2025 Filed Jan 6, 2025 22:52 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 14,349 Not disclosed Not disclosed
Disclosure

SEC source: 0001666071-25-000010 · wk-form4_1736203958.xml · nonDerivative · entry 1

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,830

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

Read SEC document
November 15, 2024 Filed Nov 15, 2024 23:30 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 25,118 $3.43 $86,154.74
Disclosure

SEC source: 0001666071-24-000171 · wk-form4_1731713436.xml · nonDerivative · entry 2

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,481

F2 · shares: Shares were sold solely to satisfy withholding tax obligations that resulted from the delivery of shares of common stock for RSUs that vested on November 15, 2024. The Reporting Person did not sell shares for any other purpose.

F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $3.32 to $3.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3)

Read SEC document
November 14, 2024 Filed Nov 15, 2024 23:30 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Units · Derivative 43,750 $0.00 $0.00
Disclosure

SEC source: 0001666071-24-000171 · wk-form4_1731713436.xml · derivative · entry 3

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,250

Underlying: Common Stock · 43,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

F4 · derivative.exercise_date: The RSU award was originally for 350,000 shares. 50% of the RSUs vested on August 14, 2024 (the "Anniversary Date"), with the remaining 50% having vested or vesting in equal amounts quarterly over the one year period following the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F4 · derivative.expiration_date: The RSU award was originally for 350,000 shares. 50% of the RSUs vested on August 14, 2024 (the "Anniversary Date"), with the remaining 50% having vested or vesting in equal amounts quarterly over the one year period following the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
November 14, 2024 Filed Nov 15, 2024 23:30 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 43,750 $0.00 $0.00
Disclosure

SEC source: 0001666071-24-000171 · wk-form4_1731713436.xml · nonDerivative · entry 1

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,599

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

Read SEC document
October 02, 2024 Filed Oct 3, 2024 11:09 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 7,487 $3.09 $23,097.40
Disclosure

SEC source: 0001666071-24-000150 · wk-form4_1727953768.xml · nonDerivative · entry 2

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,849

F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on October 1, 2024. The Reporting Person did not sell shares for any other purpose.

F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $3.05 to $3.145, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).

Read SEC document
October 01, 2024 Filed Oct 3, 2024 11:09 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Units · Derivative 14,350 $0.00 $0.00
Disclosure

SEC source: 0001666071-24-000150 · wk-form4_1727953768.xml · derivative · entry 3

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,097

Underlying: Common Stock · 14,350 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

F4 · derivative.exercise_date: The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F4 · derivative.expiration_date: The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 11:09 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 14,350 Not disclosed Not disclosed
Disclosure

SEC source: 0001666071-24-000150 · wk-form4_1727953768.xml · nonDerivative · entry 1

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,336

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:22 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 90,912 $3.71 $337,101.70
Disclosure

SEC source: 0001666071-24-000138 · wk-form4_1723839735.xml · nonDerivative · entry 2

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,986

F2 · shares: Shares were sold solely to satisfy withholding tax obligations that resulted from the delivery of shares of common stock for RSUs that vested on August 14, 2024. The Reporting Person did not sell shares for any other purpose.

F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $3.535 to $3.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).

Read SEC document
August 14, 2024 Filed Aug 16, 2024 20:22 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Units · Derivative 175,000 $0.00 $0.00
Disclosure

SEC source: 0001666071-24-000138 · wk-form4_1723839735.xml · derivative · entry 3

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Stock · 175,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

F4 · derivative.exercise_date: The RSU award was originally for 350,000 shares. 50% of the RSUs vested on August 14, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over the one year period following the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F4 · derivative.expiration_date: The RSU award was originally for 350,000 shares. 50% of the RSUs vested on August 14, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over the one year period following the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
August 14, 2024 Filed Aug 16, 2024 20:22 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 175,000 $0.00 $0.00
Disclosure

SEC source: 0001666071-24-000138 · wk-form4_1723839735.xml · nonDerivative · entry 1

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 181,898

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

Read SEC document
July 02, 2024 Filed Jul 2, 2024 23:11 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 7,451 $7.95 $59,257.80
Disclosure

SEC source: 0001666071-24-000117 · wk-form4_1719961853.xml · nonDerivative · entry 2

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,898

F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on July 1, 2024. The Reporting Person did not sell shares for any other purpose.

F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $7.85 to $8.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).

Read SEC document
July 01, 2024 Filed Jul 2, 2024 23:11 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Units · Derivative 14,349 $0.00 $0.00
Disclosure

SEC source: 0001666071-24-000117 · wk-form4_1719961853.xml · derivative · entry 3

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,447

Underlying: Common Stock · 14,349 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

F4 · derivative.exercise_date: The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F4 · derivative.expiration_date: The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 23:11 UTC Cardlytics, Inc. CDLX · Entity 7603 GrantCommon Stock 14,349 Not disclosed Not disclosed
Disclosure

SEC source: 0001666071-24-000117 · wk-form4_1719961853.xml · nonDerivative · entry 1

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,349

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

Read SEC document
March 22, 2024 Filed Mar 25, 2024 11:29 UTC Cardlytics, Inc. CDLX · Entity 7603 GrantRestricted Stock Unit · Derivative 114,796 $0.00 $0.00
Disclosure

SEC source: 0001666071-24-000048 · wk-form4_1711366148.xml · derivative · entry 1

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,796

Underlying: Common Stock · 114,796 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

F2 · derivative.exercise_date: The RSUs shall vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F2 · derivative.expiration_date: The RSUs shall vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document
August 14, 2023 Filed Aug 14, 2023 20:08 UTC Cardlytics, Inc. CDLX · Entity 7603 GrantRestricted Stock Units · Derivative 350,000 $0.00 $0.00
Disclosure

SEC source: 0001666071-23-000113 · wk-form4_1692043686.xml · derivative · entry 1

DeSieno Alexis · CIK 0001987391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 350,000

Underlying: Common Stock · 350,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

F2 · derivative.exercise_date: 50% of the RSUs shall vest on August 14, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over one year after the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date.

F2 · derivative.expiration_date: 50% of the RSUs shall vest on August 14, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over one year after the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.